Skip to main content
. 2020 Apr 7;10(4):219. doi: 10.3390/brainsci10040219

Table 1.

Melatonin level assessment in the group of patients with autism spectrum disorder (ASD).

References Number of Patients Material Results
Nir I et al., 1995 [49] 10 patients with ASD
5 controls
serum 1. Similar results of mean daily melatonin levels were measured in serum in the group of patients with ASD and the control group.
2. Patients with ASD showed lower melatonin levels at night and higher during the day relative to the control group.
Tordjman S et al., 2005 [47] 49 patients with ASD
88 controls
urine 1. Low melatonin levels were observed in 63% (31/49) of patients with ASD.
2. In pre-pubertal period, a reduction in 6-SM was apparently observed in patients with ASD relative to the control group.
Melke J et al., 2008 [37] 43 patients with ASD
34 parents
48 controls
plasma 1. Low melatonin levels were observed in 65% of patients with ASD.
2. There is a genetic potential for reduced melatonin levels in ASD, as asymptomatic parents also have abnormally low melatonin levels.
3. The results suggest that in patients with ASD and low melatonin levels we can get sleep improvement through supplementation.
Tordjman S et al., 2012 [43] 43 patients with ASD
26 controls
urine Patients with ASD showed lower levels of nocturnal 6-SM excretion in urine than those in the control group.
Pagan C et al., 2014 [41] 278 patients with ASD
129 unaffected siblings
377 parents
416 controls
plasma Melatonin levels in patients with ASD and their relatives were significantly lower than in the control group.
Abdulamir HA et al., 2016 [50] 60 patients with ASD
26 controls
serum 1. Patients with ASD presented lower levels of melatonin than the control group.
2. A relationship has been demonstrated between the severity of autism and lower melatonin levels.
Benabou M et al., 2017 [51] 157 patients with ASD
100 unaffected siblings
264 parents
plasma Phenotypic variation and changes in melatonin levels in patients with ASD and their families are the result of environmental and genetic factors.
Braam W et al., 2018 [11] 60 mothers of a child with ASD
15 controls
urine 1. Mothers of children with ASD had significantly lower levels of 6-SM in urine compared to the control group.
2. Mothers of children with ASD were older at the time of child birth compared to mothers of children without ASD.
Maruani A et al., 2019 [52] 78 patients with ASD
90 unaffected relatives
47 controls
plasma 1. Patients with ASD presented lower levels of melatonin than their relatives and people from the control group.
2. Lower levels of melatonin were observed in relatives of patients with ASD, however, the result was not statistically significant.